About the job
At Alleviate Health, we are pioneering the development of AI agents designed to significantly streamline clinical trials by autonomously engaging with patients for recruitment and ongoing support. Our mission is to resolve a critical issue that haunts executives at the world’s largest pharmaceutical companies, valued at over $100 billion.
Having successfully bootstrapped our operations, we've secured major enterprise accounts and are experiencing substantial market demand. Following a successful $4.3 million seed funding round led by a16z, we are assembling a top-tier team to tackle one of the most pressing challenges in drug development while drastically reducing the timeline for delivering life-saving medications to those in need.
Context:
The process of conducting clinical trials is complex, fraught with challenges, and carries significant financial stakes. Pharmaceutical companies allocate tens of billions annually to ensure they can qualify and screen vast numbers of patients while maintaining contact over extended periods. Remarkably, around 80% of clinical trials are delayed due to recruitment issues, costing between $600,000 and $8 million for each day a trial is postponed.
This labor-intensive challenge of patient screening, recruitment, and retention across numerous research sites is a fundamental bottleneck in clinical trials.
About Alleviate:
At Alleviate, we have developed state-of-the-art AI agents that autonomously manage patient recruitment and retention for clinical trials. Our agents conduct over 100,000 conversations monthly by:
- Intelligently screening and routing patients to appropriate trials.
- Collecting essential trial data from patients multiple times a week.
- Providing accurate answers to patient inquiries.